Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
21842101000001111 | Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
58644301000001111 | Fenoterol 1.25mg/4ml / Ipratropium 500micrograms/4ml nebuliser liquid unit dose vials 20 unit dose | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has VMP | Fenoterol 1.25mg/4ml / Ipratropium 500micrograms/4ml nebuliser liquid unit dose vials | true | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has VMP | Fenoterol 1.25mg/4ml / Ipratropium 500micrograms/4ml nebuliser liquid unit dose vials | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has dispensed dose form | Nebuliser liquid | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Is pack of | Fenoterol hydrobromide+ipratropium bromide 500micrograms/1.25mg nebulization unit | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has dispensed dose form | Nebuliser liquid | true | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has active ingredient | Ipratropium | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has active ingredient | Ipratropium bromide | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has active ingredient | Fenoterol hydrobromide | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has manufactured dose form | Nebulizer liquid | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has VMP | Fenoterol hydrobromide+ipratropium bromide 500micrograms/1.25mg nebulization unit | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has specific active ingredient | Ipratropium bromide | true | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has specific active ingredient | Fenoterol hydrobromide | true | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Has dispensed dose form | Nebulizer liquid | false | Inferred relationship | Existential restriction modifier | ||
Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Duovent UDVs nebuliser liquid 4ml (Boehringer Ingelheim Ltd) 20 unit dose 2 x 10 x 4ml unit dose vials | Is a | True | Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Inferred relationship | Existential restriction modifier | |
Duovent UDVs nebuliser liquid 4ml (Sigma Pharmaceuticals Plc) 20 unit dose | Is a | True | Fenoterol 312.5micrograms/ml / Ipratropium 125micrograms/ml nebuliser liquid 4ml unit dose vials 20 unit dose | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets